Blood advances
eISSN: 2473-9537pISSN: 2473-9529
Share this on:
Key Metrics
CiteScore 
9
Eigenfactor
0.01 - 0.05
Impact Factor
5 - 10
Scite Index
0.89 5-Year SI
SJR
Q1Hematology
SNIP
1
Topics Covered
Overall survival
Platelet
Heparin
Bone marrow
Allele
Hematopoietic stem cell transplantation
Immunotherapy
Anticoagulant
Toxicity
Progression-free survival
Central nervous system
Rituximab
B-cell lymphoma
Myeloid cells
Mass spectrometry
Antigen
Hemoglobin
Amyloidosis
Germline
Cell therapy
Journal Specifications
Indexed in the following public directories
Scopus 
Web of Science
Overview
- PublisherElsevier
- LanguageEnglish
- FrequencySemi-monthly
- Article Processing ChargesUSD 3000
General Details
- LanguageEnglish
- FrequencySemi-monthly
- Publication Start Year2016
- Publisher URL
Publication Details
View less
Planning to publish in Blood advances ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers
Association of TIM-3 checkpoint receptor expression on T cells with treatment-free remission in chronic myeloid leukemia
- 13 Jun 2023
- Blood Advances
Safety and efficacy of tisagenlecleucel plus pembrolizumab in patients with r/r DLBCL: phase 1b PORTIA study results
- 13 Jun 2023
- Blood Advances
Structural connectivity mediates the relationship between blood oxygenation and cognitive function in sickle cell anemia
- 13 Jun 2023
- Blood Advances
Real-world experience with low-dose IL-2 for children and young adults with refractory chronic graft-versus-host disease
- 24 May 2023
- Blood Advances
MAF functions as a pioneer transcription factor that initiates and sustains myelomagenesis
- 24 May 2023
- Blood Advances
The chemokines IP-10/CXCL10 and IL-8/CXCL8 are potential novel biomarkers of warm autoimmune hemolytic anemia
- 23 May 2023
- Blood Advances
Association of TIM-3 checkpoint receptor expression on T cells with treatment-free remission in chronic myeloid leukemia
- 13 Jun 2023
- Blood Advances
Safety and efficacy of tisagenlecleucel plus pembrolizumab in patients with r/r DLBCL: phase 1b PORTIA study results
- 13 Jun 2023
- Blood Advances
Structural connectivity mediates the relationship between blood oxygenation and cognitive function in sickle cell anemia
- 13 Jun 2023
- Blood Advances
Real-world experience with low-dose IL-2 for children and young adults with refractory chronic graft-versus-host disease
- 24 May 2023
- Blood Advances
MAF functions as a pioneer transcription factor that initiates and sustains myelomagenesis
- 24 May 2023
- Blood Advances
The chemokines IP-10/CXCL10 and IL-8/CXCL8 are potential novel biomarkers of warm autoimmune hemolytic anemia
- 23 May 2023
- Blood Advances
FAQs
How long has Blood advances been actively publishing? 
Blood advances has been in operation since 2016 till date.
What is the publishing frequency of Blood advances?
Blood advances published with a Semi-monthly frequency.
How many articles did Blood advances publish last year?
In 2022, Blood advances publsihed 679 articles.
What is the eISSN & pISSN for Blood advances?
For Blood advances, eISSN is 2473-9537 and pISSN is 2473-9529.
What is Citescore for Blood advances?
Citescore for Blood advances is 9.
What is SNIP score for Blood advances?
SNIP score for Blood advances is 1.
What is the SJR for Blood advances?
SJR for Blood advances is Q1.
Who is the publisher of Blood advances?
Elsevier is the publisher of Blood advances.